- Home
- GEHC vs CTVA Comparison
GEHC vs CTVA Comparison
Compare GEHC & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEHC
- CTVA
- Stock Information
- Founded
- GEHC 1892
- CTVA 2018
- Country
- GEHC United States
- CTVA United States
- Employees
- GEHC N/A
- CTVA N/A
- Industry
- GEHC Computer Software: Prepackaged Software
- CTVA Farming/Seeds/Milling
- Sector
- GEHC Technology
- CTVA Consumer Staples
- Exchange
- GEHC Nasdaq
- CTVA Nasdaq
- Market Cap
- GEHC 37.5B
- CTVA 44.1B
- IPO Year
- GEHC N/A
- CTVA N/A
- Fundamental
- Price
- GEHC $78.91
- CTVA $57.48
- Analyst Decision
- GEHC Buy
- CTVA Buy
- Analyst Count
- GEHC 13
- CTVA 18
- Target Price
- GEHC $95.46
- CTVA $65.31
- AVG Volume (30 Days)
- GEHC 3.3M
- CTVA 4.0M
- Earning Date
- GEHC 02-13-2025
- CTVA 02-05-2025
- Dividend Yield
- GEHC 0.18%
- CTVA 1.18%
- EPS Growth
- GEHC 8.27
- CTVA N/A
- EPS
- GEHC 3.65
- CTVA 0.98
- Revenue
- GEHC $19,559,000,000.00
- CTVA $16,637,000,000.00
- Revenue This Year
- GEHC $2.72
- CTVA $0.62
- Revenue Next Year
- GEHC $4.08
- CTVA $2.34
- P/E Ratio
- GEHC $21.62
- CTVA $60.71
- Revenue Growth
- GEHC 1.43
- CTVA N/A
- 52 Week Low
- GEHC $71.31
- CTVA $44.01
- 52 Week High
- GEHC $94.55
- CTVA $64.20
- Technical
- Relative Strength Index (RSI)
- GEHC 36.91
- CTVA 41.04
- Support Level
- GEHC $80.47
- CTVA $56.16
- Resistance Level
- GEHC $81.78
- CTVA $60.10
- Average True Range (ATR)
- GEHC 1.56
- CTVA 1.25
- MACD
- GEHC -0.26
- CTVA -0.48
- Stochastic Oscillator
- GEHC 31.35
- CTVA 20.85
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.